Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 110

    1.

    Interaction between fosamprenavir, with and without ritonavir, and nevirapine in human immunodeficiency virus-infected subjects.

    DeJesus E, Piliero PJ, Summers K, Wire MB, Stein DS, Masterman A, Lou Y, Min SS, Shelton MJ.

    Antimicrob Agents Chemother. 2006 Sep;50(9):3157-9.PMID: 16940117 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity.

    Saliu OY, Sofer C, Stein DS, Schwander SK, Wallis RS.

    J Infect Dis. 2006 Aug 15;194(4):486-92. Epub 2006 Jul 10.PMID: 16845632 [PubMed - indexed for MEDLINE]Related articles

    3.

    Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitor.

    Ford SL, Reddy YS, Anderson MT, Murray SC, Fernandez P, Stein DS, Johnson MA.

    Antimicrob Agents Chemother. 2006 Jun;50(6):2201-6.PMID: 16723584 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Mis-specified cells die by an active gene-directed process, and inhibition of this death results in cell fate transformation in Drosophila.

    Werz C, Lee TV, Lee PL, Lackey M, Bolduc C, Stein DS, Bergmann A.

    Development. 2005 Dec;132(24):5343-52. Epub 2005 Nov 9.PMID: 16280349 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.

    Ford SL, Wire MB, Lou Y, Baker KL, Stein DS.

    Antimicrob Agents Chemother. 2005 Jan;49(1):467-9.PMID: 15616339 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pharmacokinetic and pharmacodynamic analysis of amprenavir-containing combination therapy in HIV-1-infected children.

    Stein DS, Lou Y, Johnson M, Randall S, Blanche S; Prob2004 Study Team.

    J Clin Pharmacol. 2004 Nov;44(11):1301-8.PMID: 15496648 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacokinetics and safety of GW433908 and ritonavir, with and without efavirenz, in healthy volunteers.

    Wire MB, Ballow C, Preston SL, Hendrix CW, Piliero PJ, Lou Y, Stein DS.

    AIDS. 2004 Apr 9;18(6):897-907.PMID: 15060437 [PubMed - indexed for MEDLINE]Related articles

    8.

    Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.

    Justice AC, Stein DS, Fusco GP, Sherrill BH, Fusco JS, Danehower SC, Becker SL, Hansen NI, Graham NM; CHORUS Program Team.

    J Clin Epidemiol. 2004 Jan;57(1):89-97.PMID: 15019015 [PubMed - indexed for MEDLINE]Related articles

    9.

    In vitro-in vivo model for evaluating the antiviral activity of amprenavir in combination with ritonavir administered at 600 and 100 milligrams, respectively, every 12 hours.

    Preston SL, Piliero PJ, Bilello JA, Stein DS, Symonds WT, Drusano GL.

    Antimicrob Agents Chemother. 2003 Nov;47(11):3393-9.PMID: 14576093 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Functional characterization and expression analysis of members of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family from Drosophila melanogaster.

    Ten Hagen KG, Tran DT, Gerken TA, Stein DS, Zhang Z.

    J Biol Chem. 2003 Sep 12;278(37):35039-48. Epub 2003 Jun 26.PMID: 12829714 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.

    Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, Deitch EA.

    Crit Care Med. 2003 Jun;31(6):1722-9.PMID: 12794411 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pharmacokinetic modeling and simulations of interaction of amprenavir and ritonavir.

    Sale M, Sadler BM, Stein DS.

    Antimicrob Agents Chemother. 2002 Mar;46(3):746-54.PMID: 11850257 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Clinical pharmacology and pharmacokinetics of amprenavir.

    Sadler BM, Stein DS.

    Ann Pharmacother. 2002 Jan;36(1):102-18. Review.PMID: 11816239 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pharmacodynamics of abacavir in an in vitro hollow-fiber model system.

    Drusano GL, Bilello PA, Symonds WT, Stein DS, McDowell J, Bye A, Bilello JA.

    Antimicrob Agents Chemother. 2002 Feb;46(2):464-70.PMID: 11796359 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pharmacokinetic study of human immunodeficiency virus protease inhibitors used in combination with amprenavir.

    Sadler BM, Gillotin C, Lou Y, Eron JJ, Lang W, Haubrich R, Stein DS.

    Antimicrob Agents Chemother. 2001 Dec;45(12):3663-8.PMID: 11709366 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Relationship between oxidative burst activity and CD11b expression in neutrophils and monocytes from healthy individuals: effects of race and gender.

    Siddiqi M, Garcia ZC, Stein DS, Denny TN, Spolarics Z.

    Cytometry. 2001 Aug 15;46(4):243-6.PMID: 11514958 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacokinetics and safety of amprenavir and ritonavir following multiple-dose, co-administration to healthy volunteers.

    Sadler BM, Piliero PJ, Preston SL, Lloyd PP, Lou Y, Stein DS.

    AIDS. 2001 May 25;15(8):1009-18.PMID: 11399983 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patients.

    Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Ong H, Livingston DH, Denny T, Deitch EA.

    Crit Care Med. 2001 Apr;29(4):728-36.PMID: 11373456 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects.

    Sadler BM, Chittick GE, Polk RE, Slain D, Kerkering TM, Studenberg SD, Lou Y, Moore KH, Woolley JL, Stein DS.

    J Clin Pharmacol. 2001 Apr;41(4):386-96.PMID: 11304895 [PubMed - indexed for MEDLINE]Related articles

    20.

    Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians.

    Stein DS, Moore KH.

    Pharmacotherapy. 2001 Jan;21(1):11-34. Review.PMID: 11191730 [PubMed - indexed for MEDLINE]Related articles

    21.

    In vivo effect of alpha(1)-acid glycoprotein on pharmacokinetics of amprenavir, a human immunodeficiency virus protease inhibitor.

    Sadler BM, Gillotin C, Lou Y, Stein DS.

    Antimicrob Agents Chemother. 2001 Mar;45(3):852-6.PMID: 11181371 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy males.

    Polk RE, Brophy DF, Israel DS, Patron R, Sadler BM, Chittick GE, Symonds WT, Lou Y, Kristoff D, Stein DS.

    Antimicrob Agents Chemother. 2001 Feb;45(2):502-8.PMID: 11158747 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing.

    Sadler BM, Gillotin C, Lou Y, Stein DS.

    Antimicrob Agents Chemother. 2001 Jan;45(1):30-7.PMID: 11120940 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults.

    McDowell JA, Lou Y, Symonds WS, Stein DS.

    Antimicrob Agents Chemother. 2000 Aug;44(8):2061-7.PMID: 10898676 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation.

    Peng AW, Milleri S, Stein DS.

    Antimicrob Agents Chemother. 2000 Jul;44(7):1974-6.PMID: 10858364 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults.

    McDowell JA, Chittick GE, Stevens CP, Edwards KD, Stein DS.

    Antimicrob Agents Chemother. 2000 Jun;44(6):1686-90.PMID: 10817729 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic function.

    Veronese L, Rautaureau J, Sadler BM, Gillotin C, Petite JP, Pillegand B, Delvaux M, Masliah C, Fosse S, Lou Y, Stein DS.

    Antimicrob Agents Chemother. 2000 Apr;44(4):821-6.PMID: 10722476 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Pharmacokinetics of [(14)C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study.

    McDowell JA, Chittick GE, Ravitch JR, Polk RE, Kerkering TM, Stein DS.

    Antimicrob Agents Chemother. 1999 Dec;43(12):2855-61.PMID: 10582871 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Abacavir: absolute bioavailability, bioequivalence of three oral formulations, and effect of food.

    Chittick GE, Gillotin C, McDowell JA, Lou Y, Edwards KD, Prince WT, Stein DS.

    Pharmacotherapy. 1999 Aug;19(8):932-42.PMID: 10453964 [PubMed - indexed for MEDLINE]Related articles

    31.

    Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.

    Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, Meehan P, Hussey S, Forcht J, Valentine FT.

    Ann Intern Med. 1999 Mar 16;130(6):510-4.PMID: 10075619 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Health Watch 2000: community health assessment in south central Ohio.

    Stanley SA, Stein DS.

    J Community Health Nurs. 1998;15(4):225-36.PMID: 9834559 [PubMed - indexed for MEDLINE]Related articles

    33.

    Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variables.

    Drusano GL, Bilello JA, Stein DS, Nessly M, Meibohm A, Emini EA, Deutsch P, Condra J, Chodakewitz J, Holder DJ.

    J Infect Dis. 1998 Aug;178(2):360-7.PMID: 9697715 [PubMed - indexed for MEDLINE]Related articles

    34.

    Is amphotericin B test dosing needed?

    Griswold MW, Briceland LL, Stein DS.

    Ann Pharmacother. 1998 Apr;32(4):475-7. No abstract available. PMID: 9562144 [PubMed - indexed for MEDLINE]Related articles

    35.

    Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.

    Stein DS.

    Obstet Gynecol. 1998 Apr;91(4):638. No abstract available. PMID: 9540960 [PubMed - indexed for MEDLINE]Related articles

    36.

    Mathematical modeling of the interrelationship of CD4 lymphocyte count and viral load changes induced by the protease inhibitor indinavir.

    Drusano GL, Stein DS.

    Antimicrob Agents Chemother. 1998 Feb;42(2):358-61.PMID: 9527786 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Drug interactions in HIV-positive patients initiated on protease inhibitor therapy.

    Preston SL, Postelnick M, Purdy BD, Petrolati J, Aasi H, Stein DS.

    AIDS. 1998 Jan 22;12(2):228-30. No abstract available. PMID: 9468380 [PubMed - indexed for MEDLINE]Related articles

    39.

    Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

    Stein DS.

    Lancet. 1997 Aug 23;350(9077):589-90. No abstract available. PMID: 9284796 [PubMed - indexed for MEDLINE]Related articles

    40.

    Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.

    Gruber SA, Gallichio M, Rosano TG, Kaplan SS, Hughes SE, Urbauer DL, Singh TP, Lempert N, Conti DJ, Stein DS, Drusano G.

    J Clin Pharmacol. 1997 Jul;37(7):575-86.PMID: 9243350 [PubMed - indexed for MEDLINE]Related articles

    41.

    The impact of public education videotapes on knowledge about cancer.

    Wilson JL, Stein DS.

    J Cancer Educ. 1997 Spring;12(1):51-4.PMID: 9095441 [PubMed - indexed for MEDLINE]Related articles

    43.

    Factors related to errors in medication prescribing.

    Lesar TS, Briceland L, Stein DS.

    JAMA. 1997 Jan 22-29;277(4):312-7.PMID: 9002494 [PubMed - indexed for MEDLINE]Related articles

    44.

    Gout secondary to ritonavir and didanosine.

    Mehlhaff DL, Stein DS.

    AIDS. 1996 Dec;10(14):1744. No abstract available. PMID: 8970701 [PubMed - indexed for MEDLINE]Related articles

    45.

    Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.

    Saravolatz LD, Winslow DL, Collins G, Hodges JS, Pettinelli C, Stein DS, Markowitz N, Reves R, Loveless MO, Crane L, Thompson M, Abrams D.

    N Engl J Med. 1996 Oct 10;335(15):1099-106.PMID: 8813040 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Interaction of Herpes Viruses with HIV: Can Antiherpes Drugs Prolong Survival Among AIDS Patients?

    Stein DS, Graham NM.

    Rev Med Virol. 1996 Sep;6(3):163-172. No abstract available. PMID: 10398456 [PubMed - as supplied by publisher]Related articles

    47.

    Endotoxin stimulates hydrogen peroxide detoxifying activity in rat hepatic endothelial cells.

    Spolarics Z, Stein DS, Garcia ZC.

    Hepatology. 1996 Sep;24(3):691-6.PMID: 8781344 [PubMed - indexed for MEDLINE]Related articles

    48.

    Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.

    Schooley RT, Campbell TB, Kuritzkes DR, Blaschke T, Stein DS, Rosandich ME, Phair J, Pottage JC, Messari F, Collier A, Kahn J.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):363-70.PMID: 8673545 [PubMed - indexed for MEDLINE]Related articles

    49.

    Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.

    Graham NM, Hoover DR, Park LP, Stein DS, Phair JP, Mellors JW, Detels R, Saah AJ.

    Ann Intern Med. 1996 Jun 15;124(12):1031-8.PMID: 8633816 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Acute thrombocytopenia secondary to the administration of the peptidomimetic HIV protease inhibitor MK-639(L735524)

    Stein DS, Dunn H, Drusano GL.

    AIDS. 1996 Jun;10(6):678-80. No abstract available. PMID: 8780825 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...